Magnesium carbonate
Magnesium carbonate is a magnesium-containing antacid used for the symptomatic relief of dyspepsia and heartburn, often combined with other antacids in proprietary preparations.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It neutralises gastric acid through an acid-base reaction, raising intragastric pH and relieving acid-related symptoms.
Prescribing in practice
- Magnesium salts can accumulate and cause toxicity in renal impairment, so use with caution and avoid in significant renal failure.
- Magnesium-based antacids tend to have a laxative effect, which is why they are often combined with constipating aluminium-containing salts.
- Antacids can reduce the absorption of various other medicines, so separate administration from interacting drugs.
Monitoring
Routine monitoring is not required for occasional use, but consider renal function in patients with impairment or those taking magnesium-containing products regularly.
Counselling the patient
- Take it for symptom relief and leave a gap between this and your other medicines.
- Tell your clinician if you have kidney problems or if indigestion is persistent or severe.
Evidence & guidelines
Antacids such as magnesium carbonate provide symptomatic relief in dyspepsia and are an established self-care option consistent with NICE guidance.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021